-
In January 2025, Roche Diagnostics launched the cobas Liat PCR System across several European countries, offering rapid, fully automated molecular testing for infectious diseases such as influenza and COVID-19, reflecting a growing trend toward rapid point-of-care molecular diagnostics.
- In September 2024, Qiagen introduced its QIAstat-Dx Respiratory SARS-CoV-2 Panel in Europe, a multiplex molecular test capable of detecting multiple respiratory pathogens simultaneously, indicating advances in comprehensive syndromic testing.
- In June 2024, BioMérieux expanded its BIOFIRE® FILMARRAY® System portfolio with new panels for antimicrobial resistance (AMR) gene detection, highlighting the increasing focus on rapid identification of resistant pathogens to guide targeted therapy.
- In November 2023, Hologic launched the Aptima® Multitest Swab Collection Kit in Europe, improving specimen collection for sexually transmitted infections, which enhances test accuracy and patient comfort.
- In March 2023, Abbott introduced the ID NOW™ COVID-19 rapid molecular test platform to more European markets, emphasizing the ongoing demand for fast, portable diagnostic solutions in response to emerging infectious diseases.
